A multi-center survey of achieving recommended lipid goals in Chinese patients with coronary artery disease in real world cardiovascular practice

International Journal of Cardiology

Volumn 153, Issue 2, 2011, Pages 211-212

  Guo, Yuan Lin ^a   Liu, Jun ^a   Li, Jian Jun ^a   Zhu, Cheng Gang ^a   Qing, Ping ^a   Jia, Yan Jun ^a   Wu, Na Qiong ^a   Nie, Shao Ping ^b   Li, Zi Cheng ^c   Zeng, He Song ^d   Yang, Ping ^e  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e JILIN UNIVERSITY   (China)

Author keywords

Coronary artery disease; Dyslipidemia; Guideline adherence; Keywords; LDL C goal; Lipid clinic; Statins

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; EZETIMIBE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; PIVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEALTH SURVEY; HUMAN; LETTER; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 81755165916     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.09.028     Document Type: Article

References (11)

1. M. Turakhia, and Z.H. Tseng Sudden cardiac death: epidemiology, mechanisms, and therapy Curr Probl Cardiol 32 2007 501 546
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III) JAMA 285 2001 2486 2497
3. J.-J. Li, Z.-L. Lu, and W.-R. Kou Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from China Coronary Secondary Prevention Study (CCSPS) Ann Med 42 2010 231 240
4. J.-J. Li, Y. Wang, and S.-P. Nie Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X Int J Cardiol 122 2007 82 84
5. S.M. Grundy, J.I. Cleeman, N.B. Merz for the coordinating Committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
6. D.G. Karalis, R.D. Subramanya, S.E. Hessen, L. Liu, and M.F. Victor Achieving optimal lipid goals in patients with coronary artery disease Am J Cardiol 107 2011 886 890
7. A.P. Levine, D.P. Mikhailidis, T. Moross, K. Benson, and M. Gor Achieving vascular risk factor targets: a survey of a London general practice Angiology 59 2008 36 46
8. H.S. Kim, Y. Wu, and S.J. Lin Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study Curr Med Res Opin 24 2008 1951 1963
9. D. Hu, J. Li, and X. Li for the China Cholesterol Education Program. Investigation of blood lipid levels and statin interventions in outpatients with coronary heart disease in China-The China Cholesterol Education Program (CCEP) Circ J 72 2008 2040 2045
10. M.P. Hermans, W. Van Mieghem, G. Vandenhoven, and E. Vissers Centralized Pan-European survey on the undertreatment of hypercholesterolemia (CEPHUS) Acta Cardiol 64 2009 177 185
11. K.K. Birtcher, A.J. Greisinger, and B.J. Brehm A secondary prevention lipid clinic reaches low-density lipoprotein cholesterol goals more often than usual cardiology care with coronary heart disease J Clin Lipidol 4 2010 46 52